Friday, May 30, 2025

Latest

PharmaDrug: A Path To Safe Supply

FULL DISCLOSURE: This content is sponsored by PharmaDrug Inc.

In this interview, David Kideckel, CEO of PharmaDrug (CSE: PHRX), discusses the company’s groundbreaking biosynthetic manufacturing method for pharmaceutical-grade cocaine. The focus is on addressing the fentanyl crisis and providing safe supply programs for overcoming illicit drug addiction. PharmaDrug aims to combat substance abuse through biosynthesis, ensuring consistent, pure, and cost-effective production of cocaine.

READ: Biosynthetic Cocaine? PharmaDrug Files Patent For Novel Manufacturing Method

David highlights the company’s history, his background, and potential markets, emphasizing harm reduction. The interview explores revenue opportunities, scalability, and ongoing regulatory efforts.


FULL DISCLOSURE: PharmaDrug is a client of Canacom Group, the parent company of The Deep Dive. Canacom Group is currently long the equity of PharmaDrug. The author has been compensated to cover PharmaDrug on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

How To Profit From $3300 Gold? An Inside Look At A Massive 300,000 Oz Project | Martino De Ciccio

We’re At The Start of a Great Silver Boom | Ross McElroy & Andy Bowering – Apollo Silver Corp

Equinox Gold Q1 Earnings: When Everything Goes Wrong

Recommended

Sterling Metals Hits 0.21% Copper Over 482.8 Metres In First Drilling At Soo Copper project

First Majestic Makes Second Major Discovery At Santa Elena In Just A Year

Related News

Pharmadrug Completes Super Smart Acquisition, Issues 64.4 Million Free Trading Shares

Pharmadrug Inc (CSE: BUZZ) announced this morning that it has completed its acquisition of Interrobang...

Monday, June 15, 2020, 02:44:06 PM

PharmaDrug Names Dr David Kideckel As Chairman, While SecureDose Finalizes Formulation

PharmaDrug (CSE: PHRX) this morning released a series of updates, headlined by the appointment of...
Tuesday, February 27, 2024, 09:44:15 AM

Who Is To Blame For The Growing Fentanyl Problem?

The United States is grappling with a relentless surge in fentanyl-related overdose deaths, marking a...
Sunday, February 11, 2024, 03:04:00 PM

PharmaDrug Subsidiary Begins Prep Work For Clinical Trial Of PD-001 For Viral Infectious Diseases

PharmaDrug (CSE: PHRX) yesterday reported that its joint venture, Sairiyo Therapeutics, has begun the process...
Friday, September 20, 2024, 08:29:02 AM

Aura Health Completes Name Change to Pharmadrug Inc

Aura Health (CSE: BUZZ) announced this morning that it has completed its name change to...

Monday, October 21, 2019, 09:28:36 AM